Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ARIPIPRAZOL NORMOGEN 20 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ARIPIPRAZOL NORMOGEN 20 MG COMPRIMIDOS

Approved

STANDARD

ARIPIPRAZOL NORMOGEN 20 MG COMPRIMIDOS

Laboratorios Normon S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Nov 8, 2023
Approval ID: 915c7231eb77b57f
Company: Laboratorios Normon S.A.
Type: Standard

Approval Details

Approval Id: 915c7231eb77b57f
Drug Cima Aemps Name: ARIPIPRAZOL NORMOGEN 20 MG COMPRIMIDOS
Register Number: 89143
Holder Company Name: Laboratorios Normon S.A.
Marketing Company Name: Laboratorios Normon S.A.
Authorization Date: 2023-11-08
Dosage Form: COMPRIMIDO
Dose: 20 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Laboratorios Normon S.A.

Active Ingredients

ARIPIPRAZOL

20 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 8, 2023

Approval ID

915c7231eb77b57f

Type

Standard

Back to CIMA-AEMPS Approvals